| XLS |
|
|
|
|
| ||
|
€ million |
Note |
2012 |
2011 | ||
| |||||
|
Sales |
[22] |
10,740.8 |
9,905.9 | ||
|
Royalty, license and commission income |
[23] |
432.1 |
370.5 | ||
|
Total revenues |
|
11,172.9 |
10,276.4 | ||
|
|
|
|
| ||
|
Cost of sales |
[24] |
–3,157.7 |
–2,785.61 | ||
|
Gross margin |
|
8,015.2 |
7,490.81 | ||
|
|
|
|
| ||
|
Marketing and selling expenses |
[25] |
–2,410.8 |
–2,385.71 | ||
|
Royalty, license and commission expenses |
[26] |
–579.8 |
–500.5 | ||
|
Administration expenses |
[27] |
–552.2 |
–535.61 | ||
|
Other operating expenses and income |
[28] |
–1,126.5 |
–417.21 | ||
|
Research and development |
[30] |
–1,511.3 |
–1,514.01 | ||
|
Amortization of intangible assets |
[31] |
–871.6 |
–1,004.7 | ||
|
Investment result |
[32] |
0.6 |
–1.0 | ||
|
Operating result |
|
963.6 |
1,132.11 | ||
|
|
|
|
| ||
|
Financial result |
[33] |
–254.6 |
–293.31 | ||
|
Profit before income tax |
|
709.0 |
838.81 | ||
|
|
|
|
| ||
|
Income tax |
[34] |
–130.0 |
–220.81 | ||
|
Profit after tax |
|
579.0 |
618.01 | ||
|
|
|
|
| ||
|
of which attributable to Merck KGaA shareholders (net income) |
|
566.7 |
606.51 | ||
|
of which attributable to non-controlling interest |
[35] |
12.3 |
11.5 | ||
|
|
|
|
| ||
|
Earnings per share (in €) |
[36] |
|
| ||
|
basic |
|
2.61 |
2.791 | ||
|
diluted |
|
2.61 |
2.791 | ||